Related Experiment Video
Updated: May 6, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Management of dabigatran-induced bleeding: expert statement
Dietmar Fries1, Alexander Giurea, Manfred Gütl
1Department of Anesthesia and Intensive Care, Medical University Innsbruck, Innsbruck, Austria.
This clinical guidance addresses dabigatran-induced bleeding, offering recommendations for managing patients experiencing this serious side effect. A pocket guide details escalated treatment measures for effective intervention.
Area of Science:
- Clinical Medicine
- Pharmacology
- Emergency Medicine
Background:
- Dabigatran, a direct thrombin inhibitor, carries a risk of bleeding complications.
- Manifest dabigatran-induced haemorrhage requires prompt and effective management strategies.
Framework:
- Development of clinical guidance for managing dabigatran-induced bleeding.
- Envisaging invasive interventions for severe cases.
Implementation:
- Creation of a pocket guide summarizing escalated treatment measures.
- Dissemination of guidance for clinical practice.
Implications:
- Improved patient outcomes in dabigatran-related bleeding events.
- Standardized approach to managing anticoagulant-associated haemorrhage.
- Enhanced preparedness for invasive interventions in critical situations.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

